Acceptability of cannabidiol in patients with psychosis

BACKGROUND: Cannabidiol (CBD) is a promising novel candidate treatment for psychosis. It has a more benign side effect profile than antipsychotic medications, and being treated with CBD is not perceived as being stigmatising. These observations suggest that patients with psychosis would find CBD to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesney, Edward, Lamper, Doga, Lloyd, Millie, Oliver, Dominic, Hird, Emily, McGuire, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608242/
https://www.ncbi.nlm.nih.gov/pubmed/36312845
http://dx.doi.org/10.1177/20451253221128445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608242/
https://www.ncbi.nlm.nih.gov/pubmed/36312845
http://dx.doi.org/10.1177/20451253221128445

Ejemplares similares